Entrada Therapeutics, Inc. (TRDA) market cap

Market cap today
$194.19M

Entrada Therapeutics, Inc. (TRDA) has a market cap of $194.19M. At the end of fiscal 2025 (December 31, 2025) its market cap was $425.30M. That is 36.9% lower than the $674.36M of fiscal 2024. Today's figure is 54.3% below the fiscal 2025 year-end. Figures as of 18 Nov 2026, 10:35 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$194.19M
Market cap, fiscal 2025
$425.30M
Change on fiscal 2024
−36.9%
Highest on record
$674.36Mfiscal 2024
Lowest on record
$423.09Mfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Entrada Therapeutics, Inc. market cap, in more detail

Across the 4 fiscal year-ends on record (2022–2025), the highest was $674.36M in fiscal 2024 and the lowest $423.09M in fiscal 2022.

History · 4 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Entrada Therapeutics, Inc. market cap, year by year

Entrada Therapeutics, Inc. (TRDA) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$194.19M—$4.96—
2025$425.30M 36.9% down$10.2841.37M
2024$674.36M 35.2% up$17.2939.00M
2023$498.73M 17.9% up$15.0933.05M
2022$423.09M—$13.5231.29M
2021——$17.12—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

More on TRDA

Entrada Therapeutics, Inc., figure by figure

Entrada Therapeutics, Inc. (TRDA) overview: price, valuation and scorecard

Entrada Therapeutics, Inc. market cap: questions and answers

What is Entrada Therapeutics, Inc.'s market cap?

Entrada Therapeutics, Inc. (TRDA) has a market cap of $194.19M. At the end of fiscal 2025 (December 31, 2025) its market cap was $425.30M. That is 36.9% lower than the $674.36M of fiscal 2024.

What are the highest and lowest market cap figures on record for Entrada Therapeutics, Inc.?

Across the 4 fiscal year-ends on record (2022–2025), the highest was $674.36M in fiscal 2024 and the lowest $423.09M in fiscal 2022.

How is Entrada Therapeutics, Inc.'s market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For Entrada Therapeutics, Inc. it is on record here for 4 fiscal years, 2022 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Entrada Therapeutics, Inc. (TRDA) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/TRDA/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.